| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/27/1999 | CN1041795C Ophthalmological preparation |
| 01/27/1999 | CN1041794C Stabilized pharmaceutical composition comprising an. HMG-COA reductase inhibitor compound |
| 01/27/1999 | CN1041793C Pharmaceutical composition of florfenicol |
| 01/26/1999 | US5863957 Porous crosslinked polymeric microbeads having cavities joined by interconnecting pores wherein at least some of the cavities at the interior of each microbead communicate with the surface of the bead |
| 01/26/1999 | US5863953 Liquid, oil-miscible carotenoid preparations |
| 01/26/1999 | US5863944 Compounds and compositions for delivering active agents |
| 01/26/1999 | US5863941 Method and composition of a topical treatment of inner ear and labyrinth symptoms |
| 01/26/1999 | US5863938 Wound healing agent comprises pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid and mixtures thereof; antioxidant; mixture of saturated and unsaturated fatty acids |
| 01/26/1999 | US5863919 Lock and key micelles and monomer building blocks therefor |
| 01/26/1999 | US5863910 Treatment of chronic inflammatory disorders of the gastrointestinal tract |
| 01/26/1999 | US5863906 Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863891 Protein fragments joined by peptide bonds |
| 01/26/1999 | US5863862 Aqueous mixture with nonthermoplastic compound and polymer |
| 01/26/1999 | US5863797 Gene fusion encoding a hypersecretor protein |
| 01/26/1999 | US5863758 Nucleic acids encoding osteogenic proteins |
| 01/26/1999 | US5863663 Wet-like cleaning wipes and like articles comprising a carrier treated with an emulsion having a continuous lipid phase |
| 01/26/1999 | US5863563 Administering a ph-raising buffer in powder form |
| 01/26/1999 | US5863562 Methods and composition for preserving media in the tip of a solution dispenser |
| 01/26/1999 | US5863560 Compositions and methods for topical application of therapeutic agents |
| 01/26/1999 | US5863559 Oral dosage form for treating migraine |
| 01/26/1999 | US5863558 Administering a controlled release antiepileptic drug wherein the dosage form comprising a nonionic protective film for protecting from fluid of the gastrointestinal environment |
| 01/26/1999 | US5863556 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds |
| 01/26/1999 | US5863555 Sustained oral delivery system comprising an antidiabetic agent and a permeation enhancer in continual contact with the mucous membrane |
| 01/26/1999 | US5863554 Administering to a mucosal membrane of vertebrate bioadhesive microspheres formed of material selected from proteins, polysaccharides, hyauronic acid esters, synthetic polymers including drugs and absorption enhancing materials |
| 01/26/1999 | US5863553 Bioerodible contraceptive suppository |
| 01/26/1999 | US5863549 Methods for the sustained release of biologically active compounds |
| 01/26/1999 | US5863545 Stabilizer of a water-soluble crosslinked anionic copolymer of acrylamide, 2-acrylamido-2-methylpropanesulfonic acid and a multiply unsaturated crosslinker; cosmetics; dermatology |
| 01/26/1999 | US5863544 Consists of hydroxy acid, polysiloxane and polyol alkyl ester; useful for therapeutical treatment of acne, mycosis, seborrhoeic dermatitis, eczema, rosacea, cutaneous aging or scalp or nail maladies |
| 01/26/1999 | US5863525 Cosmetic formulation |
| 01/26/1999 | US5863520 Images for medical diagnosis of organs |
| 01/26/1999 | US5862999 Method of grinding pharmaceutical substances |
| 01/26/1999 | CA2152962C Preservative system for contact lens solutions |
| 01/26/1999 | CA2140032C Cross-linked amylose material for enzymatically controlled drug release |
| 01/26/1999 | CA2137573C Pharmaceutical compositions containing nsaid and bile acids |
| 01/26/1999 | CA2136843C Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 01/26/1999 | CA2069747C Cosmetic technology |
| 01/26/1999 | CA2065773C Gastroresistant pharmaceutical formulations for oral administration containing bile acids |
| 01/26/1999 | CA2059865C Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 01/26/1999 | CA2006511C Percutaneous preparation of tulobuterol |
| 01/26/1999 | CA1340354C Periodontium-regenerative materials |
| 01/25/1999 | CA2243827A1 Veterinary composition for treating epidermal irritations |
| 01/21/1999 | WO1999002685A1 Interleukin-3 gene therapy for cancer |
| 01/21/1999 | WO1999002665A1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 01/21/1999 | WO1999002597A1 Starch-based thermoplastic mixture containing at least one cationic starch and at least one anionic starch, method for producing the mixture, and use of the same |
| 01/21/1999 | WO1999002542A1 New formulation |
| 01/21/1999 | WO1999002539A1 Diphosphonic acid salts for the treatment of osteoporosis |
| 01/21/1999 | WO1999002252A1 Improvements in or relating to capsules |
| 01/21/1999 | WO1999002208A1 Apparatus and methods for dispensing pet care substances |
| 01/21/1999 | WO1999002187A2 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | WO1999002186A2 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | WO1999002183A2 A method of inducing a ctl response |
| 01/21/1999 | WO1999002182A2 Non-aqueous vaccines |
| 01/21/1999 | WO1999002180A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | WO1999002160A1 High-purity ciprofloxacine solutions for infusion |
| 01/21/1999 | WO1999002158A1 Stable medicinal compositions containing 4,5-epoxymorphinane derivatives |
| 01/21/1999 | WO1999002151A1 Paclitaxel compositions containing hyaluronic acid of a molecular weight of less than 750.000 da |
| 01/21/1999 | WO1999002149A1 Use of petroselinum acid for treating inflammations |
| 01/21/1999 | WO1999002148A1 Nitric oxide inhibits rhinovirus infection |
| 01/21/1999 | WO1999002147A1 Improved methods and compositions for treating male erectile dysfunction |
| 01/21/1999 | WO1999002142A2 Novel composition comprising an ssri and a beta-blocker |
| 01/21/1999 | WO1999002141A1 Block copolymer |
| 01/21/1999 | WO1999002140A1 Process for preparing fast dispersing solid oral dosage form |
| 01/21/1999 | WO1999002139A1 Methods for universally distributing therapeutic agents to the brain |
| 01/21/1999 | WO1999002138A1 Delivery of hypericum perforatum (st. john's wort) in tablet form |
| 01/21/1999 | WO1999002137A1 Soluble coated chewable tablet containing rubber |
| 01/21/1999 | WO1999002136A1 Method and device for producing a multi-layer, physiologically tolerated presentation form |
| 01/21/1999 | WO1999002135A1 Microparticles for controlled delivery of biologically active molecules |
| 01/21/1999 | WO1999002134A2 Method for producing active agent preparations with controlled release from a matrix |
| 01/21/1999 | WO1999002133A2 Topical application of a combination of benzoyl peroxide and a second active ingredient |
| 01/21/1999 | WO1999002132A2 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | WO1999002131A2 Microparticles based on hybrid polymeric materials for controlled release of biologically active molecules, a process for preparing the same and their uses for in vivo and in vitro therapy, prophylaxis and diagnostics |
| 01/21/1999 | WO1999002130A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 01/21/1999 | WO1999002046A1 Flavor enhancement process |
| 01/21/1999 | WO1999002041A1 Satiety product |
| 01/21/1999 | WO1998047491A3 Controlled release formulations using intelligent polymers |
| 01/21/1999 | WO1998046273A3 Delivery system for gene therapy to the brain |
| 01/21/1999 | WO1998044884A3 Vaginal tampon and process for producing the same |
| 01/21/1999 | WO1998043609A3 Chitosane microspheres |
| 01/21/1999 | CA2303430A1 Nitric oxide inhibits rhinovirus infection |
| 01/21/1999 | CA2303210A1 Salts of diphosphonic acids and amino-alcohols for the treatment of osteoporosis |
| 01/21/1999 | CA2296056A1 Methods for universally distributing therapeutic agents to the brain |
| 01/21/1999 | CA2295976A1 Block copolymer |
| 01/21/1999 | CA2295964A1 A method of inducing a ctl response |
| 01/21/1999 | CA2295822A1 Novel composition |
| 01/21/1999 | CA2295740A1 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | CA2295735A1 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | CA2295647A1 Thermoplastic mixture based on starch, comprising at least one cationic and at least one anionic starch, its use and process for its preparation |
| 01/21/1999 | CA2295646A1 Delivery of hypericum perforatum (st. john's wort) in tablet form |
| 01/21/1999 | CA2295595A1 Improved methods and compositions for treating male erectile dysfunction |
| 01/21/1999 | CA2295516A1 Apparatus and methods for dispensing pet care substances |
| 01/21/1999 | CA2295237A1 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | CA2294865A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | CA2294817A1 Use of petroselinum acid for treating inflammations |
| 01/21/1999 | CA2290736A1 Interleukin-3 gene therapy for cancer |
| 01/20/1999 | EP0891948A1 Aluminium oxide containing solid of high specific surface |
| 01/20/1999 | EP0891776A1 Simethicone/anhydrous calcium phosphate compositions |
| 01/20/1999 | EP0891775A1 Remedies for bladder disorders |
| 01/20/1999 | EP0891774A2 Process for producing sustained release preparation |
| 01/20/1999 | EP0891770A1 Killer T cell activator and use thereof |